Literature DB >> 6235336

Use of megadoses of vitamins with minerals in Down syndrome.

G F Smith, D Spiker, C P Peterson, D Cicchetti, P Justine.   

Abstract

To evaluate the effects of megadoses of vitamins with minerals on the cognitive intelligence of children with Down syndrome, a two-group double-blind clinical trial was carried out with 56 school-aged children with Down syndrome. Children were evaluated at baseline, 4 months, and 8 months with a battery of standard psychologic tests, physical examinations, and blood tests. The two groups, which were well-matched is cognitive intelligence and other important subject characteristics at baseline, were not significantly different in intelligence and other test scores at the 4- or 8-month test periods. The particular megadoses of vitamins with minerals used in the study did not produce increased intelligence in the study population.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6235336     DOI: 10.1016/s0022-3476(84)80118-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  6 in total

Review 1.  Megavitamin and megamineral therapy in childhood. Nutrition Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1990-11-15       Impact factor: 8.262

2.  Down's syndrome and the general practitioner.

Authors:  G Howells
Journal:  Occas Pap R Coll Gen Pract       Date:  1990-11

Review 3.  Down's syndrome and the general practitioner.

Authors:  G Howells
Journal:  J R Coll Gen Pract       Date:  1989-11

4.  Supplementation with antioxidants and folinic acid for children with Down's syndrome: randomised controlled trial.

Authors:  Jill M Ellis; Hooi Kuan Tan; Ruth E Gilbert; David P R Muller; William Henley; Robert Moy; Rachel Pumphrey; Cornelius Ani; Sarah Davies; Vanessa Edwards; Heather Green; Alison Salt; Stuart Logan
Journal:  BMJ       Date:  2008-02-21

5.  Placebo Responses in Genetically Determined Intellectual Disability: A Meta-Analysis.

Authors:  Aurore Curie; Kathy Yang; Irving Kirsch; Randy L Gollub; Vincent des Portes; Ted J Kaptchuk; Karin B Jensen
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

6.  Effect of leucovorin (folinic acid) on the developmental quotient of children with Down's syndrome (trisomy 21) and influence of thyroid status.

Authors:  Henri Blehaut; Clotilde Mircher; Aimé Ravel; Martine Conte; Veronique de Portzamparc; Gwendael Poret; Françoise Huon de Kermadec; Marie-Odile Rethore; Franck G Sturtz
Journal:  PLoS One       Date:  2010-01-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.